Subscribe Now
Member Sign In
Rewards
Member Sign Out
Sections
About us
Research topics
Membership
Conferences
Webinars
Videos
More
Subscribe
Sign In
Sign Out
Cancer & Disease Research
Degenerative diseases
Infectious diseases
Inherited diseases
Neuroscience
Monoclonal antibodies
Cell therapy
Personalized medicine
Disease screening
Degenerative diseases
Infectious diseases
Inherited diseases
Neuroscience
Monoclonal antibodies
Cell therapy
Personalized medicine
Disease screening
Create a FREE account so you can:
Get the latest life sciences research and
industry news, delivered straight to your
inbox, for FREE.
Enter your Email Address to become a member:
Email Address:
Register
Already have an account?
Sign in
Sign in using your social networking account:
What's this?
Sign in using your social networking
account:
(What's this?)
|
Biotech licenses drug discovery platform from Harvard, Tufts to study complex CNS diseases
Unravel Biosciences has licensed a drug discovery platform from Harvard University and Tufts University to decode and model complex central nervous system (CNS) diseases.
Read More
Preclinical data on long-acting tuberculosis drug raises hopes for simplified treatment
A long-acting injectable formulation of rifabutin has delivered high plasma concentrations for 16 weeks in mice, resulting in the prevention of tuberculosis and the clearing of the pathogen from the lungs.
Read More
Link between genes, mitochondrial DNA reveals way to tackle cardiovascular disease
The discovery of a link between mitochondria, inflammation, and a pair of genes that help regulate blood cell growth has revealed a potential new target for atherosclerosis therapies.
Read More
1
Conferences
More Conferences »»
Science Briefs
More articles »
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Learn More
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Learn More
Connect
Tweets by @ScienceBoard